Skip to main content

Institutional filer profile

Opaleye Management Inc. Insider Trades

Latest reported as Corporate insider of Grace Therapeutics, Inc. (GRCE).

Purchase filings
35
Reported companies
5
Net open-market value
$3,137,622
Latest transaction
Oct 26, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 26, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase87,801$1.81$158,604
Oct 23, 2026Alpha Cognition Inc. (ACOG)Corporate insiderOpen Market Purchase32,090$8.28$265,821
Oct 19, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase4,256$1.88$8,001
Oct 16, 2026Alpha Cognition Inc. (ACOG)Corporate insiderOpen Market Purchase36,940$8.35$308,575
Oct 16, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase71,065$1.92$136,175
Oct 12, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase14,632$2.03$29,682
Oct 5, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase60,490$2.05$123,817
Oct 1, 2026Alpha Cognition Inc. (ACOG)Corporate insiderOpen Market Purchase19,050$8.69$165,634
Sep 29, 2026Grace Therapeutics, Inc. (GRCE)Corporate insiderOpen Market Purchase7,849$2.09$16,404
Sep 25, 2026Alpha Cognition Inc. (ACOG)Corporate insiderOpen Market Purchase31,763$8.53$270,802